Back to search
Persistent or Chronic ITP
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Persistent or Chronic ITP trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Persistent or Chronic ITP trials you may qualify forImmune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelet count, purpura, and hemorrhagic episodes caused by antiplatelet a…
Primary immune thrombocytopenia (ITP) is an autoimmune disease mainly mediated by autoreactive B cells and the presence of pathogenic anti-platelet auto-antibod…
This was a randomized, double-blind study of rilzabrutinib in patients with persistent or chronic ITP, with an average platelet count of \<30,000/μL (and no sin…
This exploratory study is to investigate the efficacy, safety and tolerability of Lusutrombopag in the treatment of primary immune thrombocytopenia in Chinese p…
This study is an extension of the TQB3473-III-01 study, aimed at evaluating the safety and efficacy of TQB3473 tablets in adult patients with persistent or chro…